AtriCure Enrolls First Patient in Randomized Multi-Center Trial Evaluating Post-Operative Afib
Go back to AtriCure Enrolls First Patient in Randomized Multi-Center Trial Evaluating Post-Operative Afib| AtriCure, Inc. (NASDAQ: ATRC) | Delayed: 54.54 +1.58 (2.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.96 | 52 Week High | $23.24 | |||
| Open | $53.53 | 52 Week Low | $13.44 | |||
| Day High | $55.16 | P/E | N/A | |||
| Day Low | $53.52 | EPS | $-0.45 | |||
| Volume | 1,098,844 | |||||
